Pat has over 25 years of experience in regulatory affairs and medical writing.  Before joining Certara’s Synchrogenix division over four years ago, she worked in leading biopharmaceutical companies such as Johnson & Johnson, Shire, and DuPont Pharmaceuticals.  She received her PhD from the University of California, Irvine, in microbiology and molecular genetics.